Particle.news
Download on the App Store

Kimberly-Clark to Acquire Kenvue in $48.7 Billion Cash-and-Stock Deal

Legal scrutiny tied to Tylenol and talc looms over the purchase.

Overview

  • Kenvue shareholders are set to receive $3.50 in cash plus 0.14625 Kimberly-Clark shares per Kenvue share, equivalent to $21.01 based on Kimberly-Clark’s prior close.
  • Post-merger ownership is expected to be roughly 54% for Kimberly-Clark shareholders and 46% for Kenvue shareholders.
  • The companies project about $32 billion in annual revenue and have identified approximately $1.9 billion in cost savings over the first three years after closing.
  • Closing is targeted for the second half of 2026, pending shareholder approvals and customary regulatory reviews.
  • Shares moved in opposite directions after the announcement, with Kimberly-Clark falling and Kenvue rising, as investors weighed a roughly 46% premium and Kenvue’s legal overhang tied to Tylenol and talc cases.